Delivery Order SPE2DB22D3004-SPE2DB25FRY80
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count unit dose packages) valued at $28,563.74. This competitively awarded, firm fixed-price delivery order is funded by the Defense Logistics Agency (DLA), a defense agency responsible for supplying pharmaceuticals and medical materiel to military health systems. The contract is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $62,597.51 by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract is scheduled for completion by August 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a relatively small transaction within AmerisourceBergen's broader federal...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $134,559.71 on August 13, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 14, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $34,787.81 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The contract is performed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for $33.4K to supply Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with performance completion scheduled for July 29, 2025, and work to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $37,183.76 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $14,586.83 contract is for the delivery of Biktarvy 50-200-25 mg tablets to a location in Conshohocken, Pennsylvania. This delivery order falls under a larger single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a...
- The Defense Logistics Agency awarded a $6,378.11 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded pharmaceutical procurement. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,715.77 by the Defense Logistics Agency on July 22, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price contract carries an ultimate completion date of July 23, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $80,409.74 to supply Biktarvy 50-200-25 mg tablets (30-count bottles) under a firm fixed-price contract with an ultimate completion date of August 4, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRY80Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 12, 2025, by the Defense Logistics Agency (DLA) for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $12,635.27, is set to be completed by August 13, 2025, and represents performance at the company's Conshohocken facility. The contract was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet federal procurement requirements through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA Medical Supply Chain continues to leverage this strategic contract vehicle to fulfill federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 8/12/25 |